Patents Assigned to Ameritox, Ltd.
  • Patent number: 9606132
    Abstract: The present disclosure provides methods for monitoring subject (e.g., patient) adherence to lurasidone therapy, for example as a component of treating a subject for a mental health disorder such as schizophrenia.
    Type: Grant
    Filed: December 11, 2014
    Date of Patent: March 28, 2017
    Assignee: AMERITOX, LTD.
    Inventors: Jeffrey Enders, Erin Strickland, Gregory L. McIntire, Ayodele Morris
  • Patent number: 9170264
    Abstract: Methods for helping to monitor subject adherence with a prescribed antipsychotic drug treatment regimen are disclosed.
    Type: Grant
    Filed: March 14, 2014
    Date of Patent: October 27, 2015
    Assignee: Ameritox, Ltd.
    Inventors: Gregory L. McIntire, Ayodele Morris
  • Publication number: 20140284467
    Abstract: Methods for helping to monitor subject adherence with a prescribed antipsychotic drug treatment regimen are disclosed.
    Type: Application
    Filed: March 14, 2014
    Publication date: September 25, 2014
    Applicant: Ameritox, Ltd.
    Inventor: Gregory L. McIntire
  • Publication number: 20140287529
    Abstract: Methods for monitoring subject compliance with a prescribed treatment regimen are disclosed. In an embodiment, the method comprises measuring a drug level in fluid of a subject and normalizing the measured drug level as a function of one or more parameters associated with the subject. The drug level can be normalized using second order quantile regression. Embodiments of the methods can use both primary and secondary metabolites in the normalization; allow changing variance by dose; allow asymmetry in variance above and below the estimated median values; and/or use analytic variables with stable estimates, such as, for example, variables associated with the percentile for ?1 standard deviation, the percentile for 0 standard deviation, and the percentile for +1 standard deviation.
    Type: Application
    Filed: March 17, 2014
    Publication date: September 25, 2014
    Applicant: AMERITOX, LTD.
    Inventor: Harry Leider
  • Publication number: 20130245960
    Abstract: Methods for monitoring subject compliance with a prescribed treatment regimen are disclosed. In one embodiment, the method comprises measuring a drug level in fluid of a subject and normalizing said measured drug level as a function of one or more parameters associated with the subject. The normalized drug level is compared to a reference value and associated confidence intervals or to a concentration range. The reference value and associated confidence intervals and/or the concentration range may be normalized based on one or more parameters associated with subjects in a reference population.
    Type: Application
    Filed: May 8, 2013
    Publication date: September 19, 2013
    Applicant: AMERITOX, LTD.
    Inventors: Harry Leider, Ariel Linden
  • Patent number: 8359207
    Abstract: The present disclosure provides methods and apparatuses for generating toxicology reports. Using the methods and apparatus disclosed herein, physicians can more easily understand toxicological lab test results. Physicians receive a toxicology report that explains, in plain language, the toxicological lab test results. A rules engine provides rules for interpreting the toxicological lab test results. Detailed explanations are associated with the rules, and the explanations appear on the toxicology report. The toxicology report greatly reduces the need for the physician to call the toxicology scientist.
    Type: Grant
    Filed: December 3, 2007
    Date of Patent: January 22, 2013
    Assignee: Ameritox, Ltd.
    Inventors: Ronald C. Backer, William Pace, Patricia Patrick, Sybil Patricia Lowry, Shesh Rau, Joel McEndree
  • Publication number: 20110224910
    Abstract: Methods for monitoring subject compliance with a prescribed treatment regimen are disclosed. In one embodiment, the method comprises measuring a drug level in fluid of a subject and normalizing said measured drug level as a function of one or more parameters associated with the subject. The normalized drug level is compared to a reference value and associated confidence intervals or to a concentration range. The reference value and associated confidence intervals and/or the concentration range may be normalized based on one or more parameters associated with subjects in a reference population.
    Type: Application
    Filed: February 11, 2011
    Publication date: September 15, 2011
    Applicant: AMERITOX, LTD.
    Inventors: Harry Leider, Ariel Linden
  • Publication number: 20110195521
    Abstract: Methods for monitoring subject compliance with a prescribed treatment regimen are disclosed. In one embodiment, the method comprises measuring a drug level in fluid of a subject and normalizing said measured drug level as a function of one or more parameters associated with the subject. The normalized drug level is compared to a reference value and associated confidence intervals or to a concentration range. The reference value and associated confidence intervals and/or the concentration range may be normalized based on one or more parameters associated with subjects in a reference population.
    Type: Application
    Filed: February 11, 2010
    Publication date: August 11, 2011
    Applicant: Ameritox, Ltd.
    Inventors: Harry Leider, Ariel Linden
  • Publication number: 20110195520
    Abstract: Methods for monitoring subject compliance with a prescribed treatment regimen are disclosed. In one embodiment, the method comprises measuring a drug level in fluid of a subject and normalizing said measured drug level as a function of one or more parameters associated with the subject. The normalized drug level is compared to a reference value and associated confidence intervals or to a concentration range. The reference value and associated confidence intervals and/or the concentration range may be normalized based on one or more parameters associated with subjects in a reference population.
    Type: Application
    Filed: February 11, 2010
    Publication date: August 11, 2011
    Applicant: AMERITOX, LTD.
    Inventors: Harry Leider, Ariel Linden
  • Publication number: 20080183503
    Abstract: The present disclosure provides methods and apparatuses for generating toxicology reports. Using the methods and apparatus disclosed herein, physicians can more easily understand toxicological lab test results. Physicians receive a toxicology report that explains, in plain language, the toxicological lab test results. A rules engine provides rules for interpreting the toxicological lab test results. Detailed explanations are associated with the rules, and the explanations appear on the toxicology report. The toxicology report greatly reduces the need for the physician to call the toxicology scientist.
    Type: Application
    Filed: December 3, 2007
    Publication date: July 31, 2008
    Applicant: Ameritox, Ltd.
    Inventors: Ronald C. Backer, William Pace, Patricia Patrick, Sybil Patricia Lowry, Shesh Rau, Joel McEndree